SCHEMBL30359461

SCHEMBL30359461

Cc1ccnc2ccc(-c3c(-c4ccccc4Cl)nc(N)c4nnnn34)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPK1 P28482 4/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ USP2 O75604 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ CNR1 P21554 4/20 0.38
▸ CNR2 P34972 2/20 0.38
▸ CLK4 Q9HAZ1 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25238696 1.00 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL25206143 0.87 KDM4E (0.38) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL30359474 0.87 KDM4E (0.38) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL30359465 0.86 TGFBR1 (0.41) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL25209828 0.86 TGFBR1 (0.41) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL25231898 0.86 MAP4K4 (0.42) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL30359463 0.86 MAP4K4 (0.42) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL25205150 0.84 MAPK1 (0.41) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL25251378 0.83 KDR (0.41) ALDH1A1MAPK1HSD17B10USP2TSHR
SCHEMBL30359460 0.83 KDR (0.41) ALDH1A1MAPK1HSD17B10USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433485-A1 ADENOSINE RECEPTOR ANTAGONISTS Crossignal Therapeutics, Inc. (US) 2024-09-25 — — EP claimed
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 — — WO claimed
EP-4433485-A1 ADENOSINE RECEPTOR ANTAGONISTS Crossignal Therapeutics, Inc. (US) 2024-09-25 — — EP disclosed
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback